HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/6/H2582    most recent 00786.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Kubo, M. Articles by Hamano, K. Search for Related Content PubMed PubMed Citation Articles by Kubo, M. Articles by Hamano, K.

TRANSLATIONAL PHYSIOLOGY

Short-term pretreatment with low-dose hydrogen peroxide enhances the efficacy of bone marrow cells for therapeutic angiogenesis

Department of Surgery and Clinical Science, Yamaguchi University, Graduate School of Medicine, Yamaguchi, Japan

Submitted 22 July 2006 ; accepted in final form 29 January 2007

Therapeutic angiogenesis can be induced by the implantation of bone marrow cells (BMCs). Hydrogen peroxide (H₂O₂) has been shown to increase VEGF expression and to be involved in angiogenesis. We tested the hypothesis that pretreatment with H₂O₂ enhances the efficacy of BMCs for neovascularization. H₂O₂ pretreatment was done by incubating mouse BMCs in 5 µM H₂O₂ for 30 min, followed by washing twice with PBS. The H₂O₂-pretreated and untreated BMCs were then studied in vitro and in vivo. RT-PCR analysis showed that expression of VEGF and Flk-1 mRNA was significantly higher in H₂O₂-pretreated BMCs than in untreated BMCs after 12 and 24 h of culture (P < 0.01). Pretreatment with H₂O₂ also effectively enhanced the VEGF production and endothelial differentiation from BMCs after 1 and 7 days of culture (P < 0.05). To estimate the angiogenic potency in vivo, H₂O₂-pretreated or untreated BMCs were intramuscularly implanted into the ischemic hindlimbs of mice. After 14 days of treatment, many of the H₂O₂-pretreated BMCs were viable, showed endothelial differentiation, and were incorporated in microvessels. Conversely, the survival and incorporation of the untreated BMCs were relatively poor. Microvessel density and blood flow in the ischemic hindlimbs were significantly greater in the mice implanted with H₂O₂-pretreated BMCs than in those implanted with untreated BMCs (P < 0.05). These results show that the short-term pretreatment of BMCs with low-dose H₂O₂ is a novel, simple, and feasible method of enhancing their angiogenic potency.

cell therapy; reactive oxygen species; differentiation

This article has been cited by other articles:

				P. J. Psaltis, A. C.W. Zannettino, S. G. Worthley, and S. Gronthos Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair Stem Cells, September 1, 2008; 26(9): 2201 - 2210. [Abstract] [Full Text] [PDF]

				M. Kubo, T.-S. Li, R. Suzuki, B. Shirasawa, N. Morikage, M. Ohshima, S.-L. Qin, and K. Hamano Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H590 - H595. [Abstract] [Full Text] [PDF]